
Isc
Medical center for stuttering and voice disorder rehabilitation.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
€2.0m | Early VC | ||
Total Funding | 000k |
EUR | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 210 % | (8 %) | (28 %) | 33 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (50 %) | (5 %) | (8 %) | (36 %) | (28 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Vivavoce Institute is a specialized medical center focused on the diagnosis and rehabilitation of stuttering, voice disorders, and other language-related difficulties. The company was founded in 2011 by Giovanni Muscarà, who personally experienced and sought to find a lasting solution for stuttering. His journey led to the development of a new methodology, initially with a team of specialists, and the establishment of the International Stuttering Centre (ISC) in London, which was renamed Vivavoce Institute in 2016. Muscarà, who has a background in Economics and International Finance, was driven by his own experiences to create an effective and scientifically-backed treatment.
The institute's core offering is a rehabilitative path based on the proprietary and scientifically validated MRM-S (Muscarà Rehabilitation Method for Stuttering). This multidisciplinary approach addresses the motor, linguistic, cognitive, and emotional dimensions of stuttering, aiming to help patients regain motor control over the organs involved in phonation. The treatment is delivered through a structured, three-phase program: an initial free evaluation, an intensive on-site course over several days, and a six-month post-course consolidation period supported by tutors and a proprietary mobile app. A key technological component is the patented Vivavoce Wall, a device that uses visual and auditory stimulation with biofeedback to improve speech fluency.
Vivavoce operates through a main center in Milan and has expanded its presence across other Italian cities like Udine, Bologna, and Rome via partnerships with local rehabilitation centers. The business model includes providing these specialized medical services to children (from age 6), adolescents, and adults. The company has received equity investment from entities like Fondazione Social Venture Giordano Dell’Amore to support its growth and social impact. In addition to its clinical services, Vivavoce runs an associated non-profit, Associazione Vivavoce, to raise awareness and support individuals with communication disorders.
Keywords: stuttering treatment, voice disorder rehabilitation, speech therapy, language disorders, MRM-S method, speech pathology, communication skills, neurorehabilitation, phonation control, biofeedback technology, logopedics, cognitive neurology, speech fluency, pediatric speech therapy, adult stuttering treatment, Vivavoce Wall, language rehabilitation, speech science, communication aids, multidisciplinary therapy